Cliff Asness's TARA Position Overview
Cliff Asness (via Aqr Capital Management LLC) currently holds 66,805 shares of Protara Therapeutics, Inc. (TARA) worth $348,053, representing 0.00% of the portfolio. First purchased in 2025-Q4, this recently established position has been held for 2 quarters.
Based on recent 13F filings, Cliff Asness has initiated a new position in TARA, representing a fresh investment thesis on this company. Largest addition occurred in Q1 2026, adding 52,124 shares.
Analysis based on 13F filings available since 2013 Q2
Cliff Asness's Protara Therapeutics (TARA) Holding Value Over Time
Track share changes against reported price movement
Quarterly Protara Therapeutics (TARA) Trades by Cliff Asness
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +52,124 | Add 355.04% | 66,805 | $5.21 |
| Q4 2025 | +14,681 | New Buy | 14,681 | $5.33 |
Cliff Asness's Protara Therapeutics Investment FAQs
Cliff Asness first purchased Protara Therapeutics, Inc. (TARA) in Q4 2025, acquiring 14,681 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness has held Protara Therapeutics, Inc. (TARA) for 2 quarters since Q4 2025.
Cliff Asness's largest addition to Protara Therapeutics, Inc. (TARA) was in Q1 2026, adding 66,805 shares worth $348,053.
According to the latest 13F filing for Q1 2026, Cliff Asness's firm, Aqr Capital Management LLC, owns 66,805 shares of Protara Therapeutics, Inc. (TARA), valued at approximately $348,053.
As of the Q1 2026 filing, Protara Therapeutics, Inc. (TARA) represents approximately 0.00% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings.
Cliff Asness's peak holding in Protara Therapeutics, Inc. (TARA) was 66,805 shares, as reported at the end of Q1 2026.